Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $52.8M invested in Invesco Biotechnology & Genome ETF in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.23M | |
| 2 | +$1.78M | |
| 3 | +$789K | |
| 4 |
LPL Financial
San Diego,
California
|
+$546K |
| 5 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$226K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$1.12M | |
| 3 | -$412K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
-$312K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$260K |